Quirze Rovira
@quirze92.bsky.social
Interested in epigenetics, cancer biology, developmental biology, TEs, single cell.
Postdoc at the Avgustinova Lab -
@irbbarcelona.bsky.social
Ultimate frisbee lover
Postdoc at the Avgustinova Lab -
@irbbarcelona.bsky.social
Ultimate frisbee lover
Reposted by Quirze Rovira
🚨🚨🚨
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
EVOMG-DN
EvoMG-DN is a European Doctoral Network funded by the Horizon Europe Marie Skłodowska-Curie Actions (MSCA), composed of 14 beneficiaries and associated partners from both academic and non-academic sectors.
www.evomg-dn.eu
October 15, 2025 at 7:02 AM
🚨🚨🚨
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Reposted by Quirze Rovira
👀 ¿Te los has perdido?
📰Las células inmunitarias de una niña de 5 meses con un tumor renal agresivo abren la puerta a nuevas terapias contra este cáncer raro
Una investigación de CNAG e @irbbarcelona.org -Institut de Recerca Sant Joan de Déu
✏️Por Esther Marmora, @abc_es
📰Las células inmunitarias de una niña de 5 meses con un tumor renal agresivo abren la puerta a nuevas terapias contra este cáncer raro
Una investigación de CNAG e @irbbarcelona.org -Institut de Recerca Sant Joan de Déu
✏️Por Esther Marmora, @abc_es
Las células inmunitarias de una niña de 5 meses con un tumor renal agresivo abren la puerta a nuevas terapias contra este cáncer raro
La buena respuesta al tratamiento de la menor, que padecía un tumor rabdoide renal, ha permitido identificar células con capacidad antitumoral en este carcinoma
www.abc.es
August 4, 2025 at 9:03 AM
👀 ¿Te los has perdido?
📰Las células inmunitarias de una niña de 5 meses con un tumor renal agresivo abren la puerta a nuevas terapias contra este cáncer raro
Una investigación de CNAG e @irbbarcelona.org -Institut de Recerca Sant Joan de Déu
✏️Por Esther Marmora, @abc_es
📰Las células inmunitarias de una niña de 5 meses con un tumor renal agresivo abren la puerta a nuevas terapias contra este cáncer raro
Una investigación de CNAG e @irbbarcelona.org -Institut de Recerca Sant Joan de Déu
✏️Por Esther Marmora, @abc_es
Congrats Sentís et al. 👏🎊
🔬An aggressive #ChildhoodCancer case opens new avenues for advanced cell therapies.
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
✍️ #IRBBarcelona, @cnag-eu.bsky.social, @sjdhospitalbarcelona.org
📰 Annals of Oncology
Read more here ➡️ bit.ly/40Ut5lC
📌 DOI: 10.1016/j.annonc.2025.05.530
#IRBScience
🧪
July 16, 2025 at 10:31 AM
Congrats Sentís et al. 👏🎊
Reposted by Quirze Rovira
Meet Dr. Alexandra Avgustinova, leading cutting-edge research at #IRBBarcelona, uncovering how epigenetics drives pediatric cancer. Her work aims to translate molecular insights into better therapies for young patients.
▶️ https://youtu.be/lkRdfyd-XB8
#CancerResearch #PediatricCancer
🧪
▶️ https://youtu.be/lkRdfyd-XB8
#CancerResearch #PediatricCancer
🧪
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
youtu.be
July 11, 2025 at 9:03 AM
Meet Dr. Alexandra Avgustinova, leading cutting-edge research at #IRBBarcelona, uncovering how epigenetics drives pediatric cancer. Her work aims to translate molecular insights into better therapies for young patients.
▶️ https://youtu.be/lkRdfyd-XB8
#CancerResearch #PediatricCancer
🧪
▶️ https://youtu.be/lkRdfyd-XB8
#CancerResearch #PediatricCancer
🧪
Reposted by Quirze Rovira
💥🥳 At long last, our latest paper is out!
Gag proteins of endogenous retroviruses are required for zebrafish development
www.pnas.org/doi/10.1073/...
Led heroically by Sylvia Chang & @jonowells.bsky.social
A study which has changed the way I think of #transposons! No less! 🧵 1/n
Gag proteins of endogenous retroviruses are required for zebrafish development
www.pnas.org/doi/10.1073/...
Led heroically by Sylvia Chang & @jonowells.bsky.social
A study which has changed the way I think of #transposons! No less! 🧵 1/n
Gag proteins encoded by endogenous retroviruses are required for zebrafish development | PNAS
Transposable elements (TEs) make up the bulk of eukaryotic genomes and examples abound
of TE-derived sequences repurposed for organismal function. ...
www.pnas.org
April 30, 2025 at 10:45 AM
💥🥳 At long last, our latest paper is out!
Gag proteins of endogenous retroviruses are required for zebrafish development
www.pnas.org/doi/10.1073/...
Led heroically by Sylvia Chang & @jonowells.bsky.social
A study which has changed the way I think of #transposons! No less! 🧵 1/n
Gag proteins of endogenous retroviruses are required for zebrafish development
www.pnas.org/doi/10.1073/...
Led heroically by Sylvia Chang & @jonowells.bsky.social
A study which has changed the way I think of #transposons! No less! 🧵 1/n
Reposted by Quirze Rovira
📢 SUPER EXCITED to share our latest preprint:
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
https://biorxiv.org/content/10.110…
January 29, 2025 at 11:07 AM
📢 SUPER EXCITED to share our latest preprint:
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid
Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
Reposted by Quirze Rovira
We’re recruiting a PhD student to use comparative omics to investigate why some viruses can efficiently infect both human and mosquito cells, but lead to different infection outcomes. Fully funded position by @evomg-bcn.bsky.social at our lab at UPF-CRG and the Diez lab.
www.crg.eu/en/content/t...
www.crg.eu/en/content/t...
December 10, 2024 at 11:33 AM
We’re recruiting a PhD student to use comparative omics to investigate why some viruses can efficiently infect both human and mosquito cells, but lead to different infection outcomes. Fully funded position by @evomg-bcn.bsky.social at our lab at UPF-CRG and the Diez lab.
www.crg.eu/en/content/t...
www.crg.eu/en/content/t...
Reposted by Quirze Rovira
Amazing new study led by my labmate Inés Sentís, leveraging #SingleCell 🖥️🧬 technologies to study the effects of #immunotherapy in #pediatric #cancer. Emphasis on
#Tcell dynamics throughout treatment and comparing circulating vs. tumor-resident immune cells 🩸💪
#Tcell dynamics throughout treatment and comparing circulating vs. tumor-resident immune cells 🩸💪
Spatio-temporal T cell tracking for personalized TCR-T designs in childhood cancer
Immune checkpoint inhibition (ICI) has revolutionized oncology, offering extended survival and long-term remission in previously incurable cancers. While highly effective in tumors with high mutationa...
www.biorxiv.org
November 20, 2024 at 10:18 AM
Amazing new study led by my labmate Inés Sentís, leveraging #SingleCell 🖥️🧬 technologies to study the effects of #immunotherapy in #pediatric #cancer. Emphasis on
#Tcell dynamics throughout treatment and comparing circulating vs. tumor-resident immune cells 🩸💪
#Tcell dynamics throughout treatment and comparing circulating vs. tumor-resident immune cells 🩸💪